Oxysterols and atherosclerosis

Atherosclerosis

Volumn 142, Issue 1, 1999, Pages 1-28

  Brown, Andrew J ^a   Jessup, Wendy ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

Author keywords

Atherosclerosis; Cholesterol; Cholesterol oxides; Oxysterol

Indexed keywords

25 HYDROXYCHOLESTEROL; 26 HYDROXYCHOLESTEROL; 7 HYDROPEROXYCHOLESTEROL; 7 HYDROXYCHOLESTEROL; 7 OXOCHOLESTEROL; CHOLESTANETRIOL; CHOLESTEROL; CHOLESTEROL 5,6 OXIDE; HYDROXYSTEROL; LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL REACTIVITY; CHOLESTEROL METABOLISM; DOSE RESPONSE; ESTERIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; OXIDATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

ANIMALS; ARTERIOSCLEROSIS; CHOLESTENONES; CHOLESTEROL; CHOLESTEROL, DIETARY; HUMANS; HYDROXYCHOLESTEROLS;

EID: 0032890337     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00196-8     Document Type: Review

References (232)

1. Smith L.L. Cholesterol autoxidation. 1981;Plenum Press, New York.
2. Smith L.L., Johnson B.H. Biological activities of oxysterols. Free. Radic. Biol. Med. 7:1989;285.
3. Smith L. Review of progress in sterol oxidations: 1987-1995. Lipids. 31:1996;453.
4. Guardiola F., Codony R., Addis P.B., Rafecas M., Boatella J. Biological effects of oxysterols: current status. Food. Chem. Toxicol. 34:1996;193.
5. Taylor C.B., Peng S.-K., Werthessen N.T., Tham P., Lee K.T. Spontaneously occurring angiotoxic derivatives of cholesterol. Am. J. Clin. Nutr. 32:1979;40.
6. Peng S.-K., Phillipis G.A., Xia G.-Z., Morin R.J. Transport of cholesterol autoxidation products in rabbit lipoproteins. Atherosclerosis. 64:1987;1.
7. Jacobson M.S., Nair P.P., Naseem S.M., Smith T.D., Heald F.P. Oxygenated cholesterols: new risk factors for atherosclerosis? Pediatric. Res. 15:1981;535.
8. Björkhem I. Assay of unesterified 7-oxocholesterol in human serum by isotope dilution-mass spectrometry. Anal. Biochem. 154:1986;497.
9. Kudo K., Emmons G.T., Casserly E.W., Via D.P., Smith L.C., St Pyrek J., Schroepfer G.J. Jr Inhibitors of sterol synthesis. Chromatography of acetate derivatives of oxygenated sterols. J. Lipid. Res. 30:1989;1097.
10. Bergstrom S., Wintersteiner O. Autoxidation of sterols in colloidal aqueous solution. The nature of the products formed from cholesterol. J. Biol. Chem. 141:1941;597.
11. Park P.S.W., Addis P.B. Methods of analysis of cholesterol oxides. Peng S.-K., Morin R.J. Biological effects of cholesterol oxides. 1991;33 CRC Press, Boca Raton, FL.
12. Maerker G., Nungesser E.H., Bunick F.J. Reaction of cholesterol 5,6-epoxides with simulated gastric juice. Lipids. 23:1988;761.
13. Malavasi B., Rasetti M.F., Roma P., Fogliatto R., Allevi P., Catapano A.L., Galli G. Evidence for the presence of 7-hydroperoxycholest-5-en-3β-ol in oxidized human LDL. Chem. Phys. Lipids. 62:1992;209.
14. Brown A.J., Leong S.-L., Dean R., Jessup W. 7-Hydroperoxycholesterol and its product in oxidized low-density lipoprotein and human atherosclerotic plaque. J. Lipid. Res. 38:1997;1730.
15. Granelli K, Appelqvist L-A. Harmonisation of methods for oxysterol analysis. First report from a workshop in Lausanne, August 28-29, 1995.
16. van de Bovenkamp P., Kosmeijer-Schuil T.G., Katan M.B. Quantification of oxysterols in Dutch foods: egg products and mixed diets. Lipids. 23:1988;1079.
17. Jacobson M.S. Cholesterol oxides in Indian ghee: possible cause of unexplained high risk of atherosclerosis in Indain immigrant populations. Lancet. 2:1987;656.
18. Pie J.E., Spahis K., Seillan C. Evaluation of oxidative degradation of cholesterol in food and food ingrediants: identification and quantification of cholesterol oxides. J. Agric. Food. Chem. 38:1990;973.
19. Addis P.B., Park P.S.W. Cholesterol oxide content in food. Peng S.-K., Morin R.J. Biological effects of cholesterol oxides. 1992;71 CRC Press, Boca Raton, FL.
20. Nielsen J.H., Olsen C.E., Duedahl C., Skibsted L.H. Isolation and quantification of cholesterol oxides in dairy products by selected ion monitoring mass spectrometry. J. Dairy. Res. 62:1995;101.
21. Angulo A.J., Romera J.M., Ramirez M., Gil A. Determination of cholesterol oxides in dairy products. Effect of storage conditions. J. Agric. Food. Chem. 45:1997;4318.
22. Vine D.F., Croft K.D., Beilin L.J., Mamo J.C. Absorption of dietary cholesterol oxidation products and incorporation into rat lymph chylomicrons. Lipids. 32:1997;887.
23. Bascoul J., Domergue N., Mourot J., Dery G., Crastes de Paulet A. Intestinal absorption and fecal excretion of 5,6α-epoxy-5α-cholesta-3β-ol by the male wistar rat. Lipids. 21:1986;744.
24. Emanual H.A., Hassel C.A., Addis P.B., Bergmann S.D., Zavoral J.W. Plasma cholesterol oxidation products (oxysterols) in human subjects fed a meal rich in oxysterols. J. Food. Sci. 56:1991;843.
25. Osada K., Sasaki E., Sugano M. Lymphatic absorption of oxidized cholesterol. Lipids. 29:1994;555.
26. Hodis H.N., Crawford D.W., Sevanian A. Cholesterol feeding increases plasma and aortic tissue cholesterol oxide levels in parallel: further evidence for the role of cholesterol oxidation in atherosclerosis. Atherosclerosis. 89:1991;117.
27. 2 inhalation technique and mass isotopomer distribution analysis to study oxygenation of cholesterol in rat. Evidence for in vivo formation of 7-oxo-, 7β-hydroxy-, 24-hydroxy-, and 25-hydroxycholesterol. J. Biol. Chem. 270:1995;20278.
28. Stalenhoef A.F.H., Kleinfeld H.A., Kosmeijer-Schuil T.G., Demacker P.N.M., Katan M.B. In vivo oxidised cholesterol in atherosclerosis. Atherosclerosis. 98:1993;113.
29. Hodis H.N., Chauhan A., Hashimoto S., Crawford D.W., Sevanian A. Probucol reduces plasma and aortic wall oxysterol levels in cholesterol fed rabbits independently of its plasma cholesterol lowering effect. Atherosclerosis. 96:1992;125.
30. Freyschuss A., Stiko-Rahm A., Swedenborg J., Henriksson P., Björkhem I., Berglund L., Nilsson J. Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta of hypercholesterolemic rabbits. J. Clin. Invest. 91:1993;1282.
31. Tamasawa N., Tamasawa A., Takebe K., Hayakari M. The effect of dietary 7-ketocholesterol, inhibitor of sterol synthesis, on hepatic microsomal cholesterol 7α-hydroxylase activity in rat. Biochim. Biophys. Acta. 1214:1994;20.
32. Björkhem I. Mechanism of degradation of the steroid side chain in the formation of bile acids. J. Lipid. Res. 33:1992;455.
33. Russell D.W., Setchell K.D. Bile acid biosynthesis. Biochemistry. 31:1992;4737.
34. Martin K., Budai K., Javitt N. Cholesterol and 27-hydroxycholesterol 7α-hydroxylation: evidence for two different enzymes. J. Lipid. Res. 34:1993;581.
35. Shoda J., Toll A., Axelson M.P., Pieper F., Wikvall K., Sjorvall J. Formation of 7α- and 7β-hydroxylated bile acid precursors from 27-hydroxycholesterol in human liver microsomes and mitochondria. Hepatology. 17:1993;395.
36. Björkhem I., Andersson O., Diczfalusy U., Sevastik B., Xiu R.-J., Duan C., Lund E. Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc. Natl. Acad. Sci. USA. 91:1994;8582.
37. Lund E., Andersson O., Zhang J. et al. Importance of a novel oxidative mechanism for elimination of intracellular cholesterol in humans. Arterioscler. Thromb. Vasc. Biol. 16:1996;208.
38. 3. Proc. Natl. Acad. Sci. USA. 91:1994;10014.
39. Pikuleva I.A., Björkhem I., Waterman M.R. Expression, purification and enzymatic properties of recombinant human cytochrome P450c27 (CYP27). Arch. Biochem. Biophys. 343:1997;123.
40. Babiker A., Andersson O., Lund E. et al. Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport. J. Biol. Chem. 272:1997;26253.
41. Crisby M., Nilsson J., Kostulas V., Björkhem I., Diczfalusy U. Localization of sterol 27-hydroxylase immuno-reactivity in human atherosclerotic plaques. Biochim. Biophys. Acta. 1344:1997;278.
42. Lutjohann D., Breuer O., Ahlborg G., Nennesmo I., Siden A., Diczfalusy U., Björkhem I. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc. Natl. Acad. Sci. USA. 93:1996;9799.
43. Björkhem I., Lutjohann D., Breuer O., Sakinis A., Wennmalm A. Importance of a novel oxidative mechanism for elimination of brain cholesterol. J. Biol. Chem. 48:1997;30178.
44. Björkhem I., Einarsson K., Johansson G. Formation and metabolism of 3β-hydroxycholest-5-en-7-one and cholest-5-ene-3β,7β-diol. Acta. Chem. Scand. 22:1968;1595.
45. Song W., Pierce W.M., Saeki Y., Redinger R.N., Prough R.A. Endogenous 7-oxoxcholesterol is an enzymatic product: characterisation of 7α-hydroxycholesterol dehydrogenase activity of hamster liver microsomes. Arch. Biochem. Biophys. 328:1996;272.
46. Mendelsohn D., Mendelsohn L., Staple E. The catabolism in vitro of cholesterol: formation of the 7-epimeric hydroxycholesterols from cholesterol in rat liver. Biochem. Biophys. Acta. 97:1965;379.
47. van Cantfort J. The in vitro formation and the strong inhibitory action of 7-ketocholesterol on cholesterol 7α-hydroxylase activity. Life. Sci. 11:1972;773.
48. Erickson S.A., Cooper A.D., Matsui S.M., Gould R.G. 7-Ketocholesterol, its effects on hepatic cholesterogenesis and its hepatic metabolism in vivo and in vitro. J. Biol. Chem. 252:1977;5186.
49. Breuer O., Sudjana-Sugiaman E., Eggertsen G., Chiang J.Y.L., Björkhem I. Cholesterol 7α-hydroxlase is up-regulated by the competitive inhibitor 7-oxocholesterol in rat liver. Eur. J. Biochem. 215:1993;705.
50. Johnson K.A., Morrow C.J., Knight G.D., Scallen T.J. In vivo formation of 25-hydroxycholesterol from endogenous cholesterol after a single meal, dietary cholesterol challenge. J. Lipid. Res. 35:1994;2241.
51. Khou I.-L., Holmes R.P. The analysis of 25-hydroxycholesterol and cholesterol-containing foods by high-performance liquid chromatography. J. Chromatogr. 330:1985;339.
52. Smith L.L., Teng J.I., Lin Y.Y., Seitz P.K., McGehee M.F. Sterol metabolism-XLVII. Oxidized cholesterol esters in human tissues. J. Steroid. Biochem. 14:1981;889.
53. Dzeletovic S., Breuer O., Lund E., Diczfalusy U. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal. Biochem. 225:1995;73.
54. Szedlacsek S.E., Wasowicz E., Hulea S.A., Nishida H.I., Kummerow F.A., Nishida T. Esterification of oxysterols by human plasma lecithin-cholesterol acyltransferase. J. Biol. Chem. 270:1995;11812.
55. Lin C.Y., Morel D.W. Esterification of oxysterols in human serum: effects on distribution and cellular uptake. J. Lipid. Res. 37:1996;168.
56. Gelissen I.C., Brown A.J., Mander E.L., Kritharides L., Dean R.T., Jessup W. Sterol efflux is impaired from macrophage foam cells selectively enriched with 7-ketocholesterol. J. Biol. Chem. 271:1996;17852.
57. Harik-Khan R., Holmes R.P. Estimation of 26-hydroxycholesterol in serum by high-performance liqid chromatography and its measurement in patients with atherosclerosis. J. Steroid. Biochem. 36:1990;351.
58. Dyer R.G., Stewart M.W., Mitcheson J., George K., Alberti M.M., Laker M.F. 7-Ketocholesterol, a specific indicator of lipoprotein oxidation, and malondialdehyde in non-insulin dependent diabetes and peripheral vascular disease. Clin. Chim. Acta. 260:1997;1.
59. Mol M.J., de Rijke Y., Demacker P.N., Stalenhoef A.F. Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment. Atherosclerosis. 129:1997;169.
60. Mori TA, Croft KD, Galbraith A, Puddey IB. A study of LDL oxysterols in female smokers and non-smokers. The absence of an effect of either vitamin C and E supplementation. Proc Aust Atheroscler Soc 1995;21(abstract).
61. van Poppel G., Kok F.J., Jahanns E., Kosmeijer T. Plasma oxysterols and coronary atherosclerosis: a case control study. Int. Congr. Nutr. (Adelaide). 795:1993;58.
62. van de Vijver L.P.L., Steyger R., van Poppel G., Boer J.M.A., Kruijssen D.A.C.M., Seidell J.C., Princen H.M.G. Antibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls. Atherosclerosis. 122:1996;245.
63. Lui K., Cuddy T.E., Pierce G.N. Oxidative status of lipoproteins in coronary disease patients. Am. Heart. J. 123:1992;285.
64. Salonen J.T., Nyyssonen K., Salonen R., Porkkala-Sataho E., Tuomainen T.-P., Diczfalusy U., Björkhem I. Lipoprotein oxidation and progression of carotid atherosclerosis. Circulation. 95:1997;840.
65. Zieden B., Diczfalusy U. Higher 7β-hydroxycholesterol in high cardiovascular risk population. Atherosclerosis. 134:1997;172.
66. Brooks C.J.W., McKenna R.M., Cole W.J., MacLachlan J., Lawrie T.D.V. Profile analysis of oxygenated sterols in plasma and serum. Biochem. Soc. Trans. 11:1983;700.
67. Addis P.B., Emanuel H.A., Bergmann S.D., Zayoral J.H. Capillary GC quantification of cholesterol oxidation products in plasma lipoproteins of fasted humans. Free. Radic. Biol. Med. 7:1989;179.
68. Javitt N.B., Kok E., Burstein S., Cohen B., Kutscher J. 26-Hydroxycholesterol. Identification and quantitation in human serum. J. Biol. Chem. 256:1981;12644.
69. Lin C.-Y., Morel D.W. Distribution of oxysterols in human serum: characterisation of 25-hydroxycholesterol association with serum albumin. J. Nutr. Biochem. 6:1995;618.
70. Tertov V.V., Sobenin I.A., Gabbasov Z.A. et al. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization. Lab. Invest. 67:1992;665.
71. Tertov V.V., Sobenin I.A., Orekhov A.N., Jaakkola O., Solakivi T., Nikkari T. Characteristics of low density lipoprotein isolated from circulating immune complexes. Atherosclerosis. 122:1996;191.
72. -). J. Lipid. Res. 35:1994;669.
73. - is a lipid hydroperoxide-enriched circulating lipoprotein. J. Lipid. Res. 38:1997;419.
74. Chang Y.H., Aballa D.S.P., Sevanian A. Characterization of cholesterol oxidation products formed by oxidative modification of low-density lipoprotein. Free. Radic. Biol. Med. 23:1997;202.
75. Brown A.J. Oxidatively-modified lipoproteins in coronary heart disease. Novel approaches to the measurement of lipid peroxidation in vivo. Br. Nutr. Found. Bull. (Suppl. 1). 17:1992;49.
76. Lamarche B., Tchernof A., Moorjani S., Cantin B., Dagenais G.R., Lupien P.J., Depres J.-P. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation. 95:1997;69.
77. de Graaf J., Hak-Lemmers H.L.M., Hectors M.P.C., Demacker P.N.M., Hendriks J.C.M., Stalenhoef A.F.H. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arteriosler. Thromb. 11:1991;298.
78. Brown A.J., Dean R.T., Jessup W. Free and esterified oxysterol: formation during copper-oxidation of low density lipoprotein and uptake by macrophages. J. Lipid. Res. 37:1996;320.
79. Jialal I., Freeman D.A., Grundy S.M. Varying susceptibility of different low density lipoproteins to oxidative modification. Arterioscler. Thromb. 11:1991;482.
80. Tanaka M., Kanamaru S. Capillary gas chromatography quantification of cholesterol in copper-oxidized low-density lipoprotein. Biol. Pharm. Bull. 16:1993;538.
81. Carpenter K.L., Wilkins G.M., Fussell B., Ballantine J.A., Taylor S.E., Mitchinson M.J., Leake D.S. Production of oxidized lipids during modification of low-density lipoprotein by macrophages or copper. Biochem. J. 304:1994;625.
82. Dzeletovic S., Babiker A., Lund E., Diczfalusy U. Time course of oxysterol formation during in vitro oxidation of low density lipoprotein. Chem. Phys. Lipids. 78:1995;119.
83. Mori T.A., Croft K.D., Puddey I.B., Beilin L.J. Analysis of native and oxidized low-density lipoprotein oxysterols using gas chromatography-mass spectrometry with selective ion monitoring. Redox. Rep. 2:1996;25.
84. Breuer O., Dzeletovic S., Lund E., Diczfalusy U. The oxysterols cholest-5-ene-3β,4α-diol, cholest-5-ene-3β,4β-diol and cholestane-3β,5α,6α-triol are formed during in vitro oxidation of low density lipoprotein, and are present in human atherosclerotic plaques. Biochim. Biophys. Acta. 1302:1996;145.
85. Patel R.P., Diczfalusy U., Dzeletovic S., Wilson M.T., Darley-Usmar V.M. Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, and copper. J. Lipid. Res. 37:1996;2361.
86. Mougenot N., Lesnik P., Ramirez G.J., Nataf P., Diczfalusy U., Chapman M.J., Lechat P. Effect of the oxidation state of LDL on the modulation of arterial vasomotor response in vitro. Atherosclerosis. 133:1997;183.
87. Chisolm G.M., Ma G., Irwin K.C. et al. 7β-Hydroperoxycholest-5-en-3β-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. Proc. Natl. Acad. Sci. USA. 91:1994;11452.
88. Caruso D., Rasetti M.F., De Angelis L., Galli G. Identification of 3β-hydroxy-5α-cholest-6-ene-5-hydroperoxide in human oxidized LDL. Chem. Phys. Lipids. 79:1996;181.
89. Deckert V., Persgol L., Viens L. et al. Inhibitors of arterial relaxation among components of human oxidized low-density lipoproteins. Cholesterol derivatives oxidized in position 7 are potent inhibitors of endothelium-dependent relaxation. Circulation. 95:1997;723.
90. Maiorino M., Thomas J.P., Girotti A.W., Ursini F. Reactivity of phospholipid hydroperoxide glutathione peroxidase with membrane and lipoprotein lipid hydroperoxides. Free. Radic. Res. Commun. 12-13:1991;131.
91. Smith L.L. Mechanisms of formation of oxysterols: a general survey. Craste de Paulet A. Free radicals, lipoproteins, and membrane lipids. 1990;115 Plenum Press, New York.
92. Nielsen J.H., Olsen C.E., Skibsted L.H. Cholesterol oxidation in a heterogeneous system initiated by water-soluble radicals. Food. Chem. 56:1996;33.
93. Hazell L.J., Stocker R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem. J. 290:1993;165.
94. Hazell L.J., van den Berg J.J.M., Stocker R. Oxidation of low-density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than lipid oxidation. Biochem. J. 302:1994;297.
95. Daugherty A., Dunn J.L., Rateri D.L., Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94:1994;437.
96. Hazell L.J., Arnold L., Flowers D., Waeg G., Malle E., Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest. 97:1996;1535.
97. Hazen S.L., Heinecke J.W. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 99:1997;2075.
98. Foote C.S., Abakerli R.B., Clough R.L., Lehrer R.I. On the question of singlet oxygen production in polymorphonuclear leucocytes. DeLuca M.A., McElroy W.D. Bioluminescence and chemiluminescence. Basic chemistry and analytical applications. 1981;81 Academic Press, New York.
99. Smith L.L. Cholesterol autoxidation 1981-1986. Chem. Phys. Lipids. 44:1987;87.
100. Heinecke J.W., Li W., Mueller D.M., Bohrer A., Turk J. Cholesterol chlorohydrin synthesis by the myeloperoxidase-hydrogen peroxide-chloride system: potential markers for lipoproteins oxidatively damaged by phagocytes. Biochemistry. 33:1994;10127.
101. Carr A.C., van den Berg J.J.M., Winterbourn C.C. Chlorination of cholesterol in cell membranes by hypochlorous acid. Arch. Biochem. Biophys. 332:1996;63.
102. Carr A.C., Winterbourn C.C., Blunt J.W., Phillips A.J., Abell A.D. Nuclear magnetic resonance characterization of 6α-chloro-5β-cholestane-3β,5-diol formed from the reaction of hypochlorous acid with cholesterol. Lipids. 32:1997;363.
103. Hardegger E., Ruzicka L., Tagmann E. Untersuchungen uber organextrakte. Zur kenntnis unversifbaren lipoide aus arteriosklerotischen aorten. Helv. Chim. Acta. 26:1943;2205.
104. Kantiengar N.L., Morton R.A. Cholesta-3:5-dien-7-one in human atherosclerotic aortas. Biochem. J. 60:1955;25.
105. Henderson A.E. A histochemical and chromatographic study of normal and atheromatous human arteries. J. Histochem. Cytochem. 4:1956;153.
106. Brooks C.J.W., Harland W.A., Steel G. Squalene, 26-hydroxycholesterol and 7-ketocholesterol in human atheromatous plaques. Biochim. Biophys. Acta. 125:1966;623.
107. van Lier J.E., Smith L.L. Sterol metabolism. I. 26-Hydroxycholesterol in the human aorta. Biochemistry. 6:1967;3269.
108. Smith L.L., van Lier J.E. Sterol metabolism. Part 9. 26-Hydroxycholesterol levels in the human aorta. Atherosclerosis. 12:1970;1.
109. Brooks C.J.W., Stell G., Gilbert J.D., Harland W.A. Lipids of human atheroma. Part 4. Characterisation of a new goup of polar sterol esters from human atherosclerotic plaques. Atherosclerosis. 13:1971;223.
110. Gilbert J., Brooks C., Harland W. Lipids of human atheroma. VII. Isolation of diesters of cholestan-5-ene-3β,26 diol from extracts of advanced atherosclerotic lesions of human aorta. Biochim. Biophys. Acta. 270:1972;149.
111. Carpenter K.L., Taylor S.E., Ballantine J.A., Fussell B., Halliwell B., Mitchinson M.J. Lipids and oxidised lipids in human atheroma and normal aorta. Biochim. Biophys. Acta. 1167:1993;121.
112. Carpenter K.L., Taylor S.E., van der Veen C., Williamson B.K., Ballantine J.A., Mitchinson M.J. Lipids and oxidised lipids in human atherosclerotic lesions at different stages of development. Biochim. Biophys. Acta. 1256:1995;141.
113. Carpenter K.L.H., Taylor S.E., van der Veen C., Mitchinson M.J. Evidence of lipid oxidation in pulmonary artery atherosclerosis. Atherosclerosis. 118:1995;169.
114. Suarna C., Dean R.T., May J., Stocker R. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate. Arterioscler. Thromb. Vasc. Biol. 15:1995;1616.
115. Mattsson-Hulten L., Lindmark H., Diczfalusy U. et al. Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages. J. Clin. Invest. 97:1996;461.
116. Kamido H., Kuksis A., Marai L., Myher J.J. Lipid ester-bound aldehydes among copper-catalyzed peroxidation products of human plasma lipoproteins. J. Lipid. Res. 36:1995;1876.
117. Hoppe G., Ravandi A., Herrera D., Kuksis A., Hoff H.F. Oxidation products of cholesteryl linoleate are resistant to hydrolysis in macrophages, form complexes with proteins, and are present in human atherosclerotic lesions. J. Lipid. Res. 38:1997;1347.
118. Gupta R., Prakash H. Association of dietary ghee with coronary heart disease and risk factor prevalence in rural males. J. Indian. Med. Assoc. 95:1997;67.
119. Imai H., Werthessen N.T., Taylor C.B., Lee K.T. Angoiotoxicity and arteriosclerosis due to contaminants of USP-grade cholesterol. Arch. Pathol. Lab. Med. 100:1976;565.
120. Kantiengar N.L., Lowe J.S., Morton R.A., Pitt G.A.J. The effects of administering cholesterol and cholesta-3:5-dien-7-one to cockerels. Biochem. J. 60:1955;34.
121. Imai H., Lee K.T. Mosaicism in female hybrid hares heterzygous for glucose-6-phosphate dehydrogenase. IV. Aortic atherosclerosis in hybrid hares fed alternating cholesterol-supplemented and nonsupplemented diets. Exp. Mol. Pathol. 39:1983;11.
122. Jacobson M.S., Price M.G., Shamoo A.E., Heald F.P. Atherogenesis in White Carneau pigeons. Effects of low-level cholestane-triol feeding. Atherosclerosis. 57:1985;209.
123. Yancey P.G., St Clair R.W. Mechanism of the defect in cholesteryl ester clearance from macrophages of atherosclerosis-susceptible White Carneau pigeons. J. Lipid. Res. 35:1994;2114.
124. Zhang H.F., Basra H.J., Steinbrecher U.P. Effects of oxidatively modified LDL on cholesterol esterification in cultured macrophages. J. Lipid. Res. 31:1990;1361.
125. Peng S.K., Taylor C.B., Hill J.C., Morin R.J. Cholesterol oxidation derivatives and arterial endothelial damage. Atherosclerosis. 54:1985;121.
126. Imai H., Werthessen N.T., Subramanyan V., LeQuesne P.W., Soloway A.H., Kanisawa M. Angiotoxicity of oxygenated sterols and possible precursors. Science. 207:1980;651.
127. Tipton C.L., Leung P.C., Johnson J.S., Brooks R.J., Beitz D.C. Cholesterol hydroperoxides inhibit calmodulin and suppress atherogenesis in rabbits. Biochem. Biophys. Res. Comm. 146:1987;1166.
128. Streuli R.A., Kanofsky J.R., Gunn R.B., Yachnin S. Diminished osmotic fragility of human erythrocytes following the membrane insertion of oxygenated sterol compounds. Blood. 58:1981;317.
129. Kritharides K., Jessup W., Mander E.L., Dean R.T. Apolipoprotein A-1-mediated efflux of sterols from oxidized LDL-loaded macrophages. Arterioscler. Thromb. 15:1995;276.
130. Kilsdonk E.P., Morel D.W., Johnson W.J., Rothblat G.H. Inhibition of cellular cholesterol efflux by 25-hydroxycholesterol. J. Lipid. Res. 36:1995;505.
131. Maor I., Aviram M. Oxidized low density lipoprotein leads to macrophage accumulation of unesterified cholesterol as a result of lysosomal trapping of the lipoprotein hydrolyzed cholesteryl ester. J. Lipid. Res. 35:1994;803.
132. Maor I., Mandl H., Aviram M. Macrophage uptake of oxidized LDL inhibits lysosomal sphingomyelinase, thus causing the accumulation of unesterified cholesterol-sphingomyelin-rich particles in the lysosomes. Arterioscler. Thromb. Vasc. Biol. 15:1995;1378.
133. Theunissen J., Jackson R., Kempen H., Demel R. Membrane porperties of oxysterols. Interfacial orientation, influence on membrane permeability and redistribution between membranes. Biochim. Biphys. Acta. 860:1986;66.
134. Rooney M., Tamura L.W., Lis L.J., Yachnin S., Kucuk O., Kauffman J.W. The influence of oxygenated sterol compounds on dipalmitoylphosphatidylcholine bilayer structure and packing. Chem. Phys. Lipids. 41:1986;81.
135. Benga G., Hodarnau A., Ionescu M. et al. A comparison of the effects of cholesterol and 25-hydroxycholesterol on egg yolk lecithin lipoposomes. A spin-label study. Ann. NY. Acad. Sci. 414:1983;140.
136. Rooney M.W., Yachnin S., Kucuk O., Lis L.J., Kauffman J.W. Oxygenated cholesterols synergistically immobilize acyl chains and enhance protein helical structure in human erythrocyte membranes. Biochim. Biophys. Acta. 820:1985;33.
137. Peng S.K., Hill J.C., Morin R.J., Taylor C.B. Influence of cholesterol oxidation derivatives on membrane bound enzymes in cultured aortic smooth muscle cells. Proc. Soc. Exp. Biol. Med. 180:1985;126.
138. Zhou Q., Jimi S., Smith T., Kummerow F. The effect of 25-hydroxycholesterol on accumulation of intracellular calcium. Cell. Calcium. 12:1991;467.
139. Krull U., Thompson M., Vandenberg E., Wong H. Langmuir-Blodgett film characteristics and phospholipid membrane ion conduction. Part 1. Modification by cholesterol and oxidized derivatives. Anal. Chim. Acta. 174:1985;83.
140. Cheng D., Chang C.C., Qu X., Chang T.Y. Activation of acyl-coenzyme A: cholesterol acyltransferase by cholesterol or by oxysterol in a cell-free system. J. Biol. Chem. 270:1995;685.
141. Jepson C., Harrison J., Kraemer F., Yeaman S. Down-regulation of hormone-sensitive lipase in sterol ester-laden J774.2 macrophages. Biochem. J. 318:1996;173.
142. Lichtenstein A.H., Brecher P. Esterification of cholesterol and 25-hydroxycholesterol by rat liver microsomes. Biochim. Biophys. Acta. 751:1983;340.
143. Korytowski W., Geiger P.G., Girotti A.W. Enzymatic reducibility in relation to cytotoxicity for various cholesterol hydroperoxides. Biochemistry. 35:1996;8670.
144. Martin K., Reiss A., Lathe R., Javitt N. 7α-Hydroxylation of 27-hydroxycholesterol: biologic role in the regulation of cholesterol synthesis. J. Lipid. Res. 37:1997;1053.
145. Stapleton G., Steel M., Richardson M., Rose J., Morris R., Lathe R. A novel cytochrome P450 expressed primarily in brain. J. Biol. Chem. 270:1995;29739.
146. Morel D.W., Edgerton M.E., Warner G.E., Johnson W.J., Phillips M.C., Rothblat G.H. Comparison of the intracellular metabolism and trafficking of 25-hydroxycholesterol and cholesterol in macrophages. J. Lipid. Res. 37:1996;2041.
147. Brown M.S., Goldstein J.L. The SREBP pathway: regluation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 89:1997;331.
148. Kandutsch A.A., Chen H.W. Inhibition of cholesterol synthesis by oxygenated sterols. Lipids. 13:1978;704.
149. Kandutsch A.A., Chen H.W., Heiniger H.J. Biological activity of some oxygenated sterols. Science. 201:1978;498.
150. Faust J., Luskey K., Chin D., Goldstein J., Brown M. Regulation of synthesis and degradation of 3-hydroxymethylglutaryl coenzyme A reductase by low density lipoprotein and 25-hydroxycholesterol in UT-1 cells. Proc. Natl. Acad. Sci. USA. 79:1982;5205.
151. Breslow J.L., Lothrop D.A., Spaulding D.R., Kandutsch A.A. Cholesterol, 7-ketocholesterol and 25-hydroxycholesterol uptake studies and effect on 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in human fibroblasts. Biochim. Biophys. Acta. 398:1975;10.
152. Lund E., Björkhem I. Role of oxysterols in the regulation of cholesterol homeostasis: a critical evaluation. Acc. Chem. Res. 28:1995;241.
153. Bell J., Sargeant T., Watson J. Inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in hepatoma tissue culture cells by pure cholesterol and several cholesterol derivatives. J. Biol. Chem. 251:1976;1745.
154. Chen H., Richards B., Kandutsch K. Inhibition of protein synthesis blocks the response to 25-hydroxycholesterol by inhibiting degradation of hydroxmethylglutaryl CoA reductase. Biochim. Biophys. Acta. 712:1982;484.
155. Brown M.S., Goldstein J.L. Regulation of the activity of the low density lipoprotein receptor in human fibroblasts. Cell. 6:1975;307.
156. Peng S.K., Zhang X., Chai N.N., Wan Y., Morin R.J. Inhibitory effect of cholesterol oxides on low density lipoprotein receptor gene expression. Artery. 22:1996;61.
157. Wang X., Sato R., Brown M.S., Hua X., Goldstein J.L. SREBP-1, a membrane bound transcription factor released by sterol-regulated proteolysis. Cell. 77:1994;53.
158. Chang T., Chang C., Cheng D. Acyl-coenzyme A: cholesterol acyltransferase. Ann. Rev. Biochem. 66:1997;613.
159. Tabas I. The stimulation of the cholesterol esterification pathway by atherogenic lipoproteins in macrophages. Curr. Opin. Lipidol. 6:1995;260.
160. Drevon C., Weinstein D., Steinberg D. Regulation of cholesterol esterification and biosynthesis in monolayer cultures of normal adult rat hepatocytes. J. Biol. Chem. 255:1980;9128.
161. Morin R., Peng S. Effects of cholesterol oxidation derivatives on cholesterol esterifying and cholesteryl ester hydrolytic activity of cultured rabbit aortic smooth muscle cells. Lipids. 24:1989;217.
162. Goldstein J.L., Brown M.S. The low-density lipoprotein pathway and its relation to atherosclerosis. Ann. Rev. Biochem. 46:1977;897.
163. Doolittle G.M., Chang T.Y. Acyl-CoA: cholesterol acyltransferase in Chinese hamster ovary cells. Enzyme activity determined after reconstitution in phospholipid/cholesterol liposomes. Biochim. Biophys. Acta. 713:1982;529.
164. Cadigan K.M., Chang T.Y. A simple method for reconstitution of CHO cell and human fibroblast acyl coenzyme A: cholesterol acyltransferase activity into liposomes. J. Lipid. Res. 29:1988;1683.
165. Bocan T.M.A., Mueller S.B., Uhlendorf P.D., Newton R.S., Krause B.R. Comparison of CI-976, An ACAT inhibitor, and selected lipid-lowering agents for antiatherosclerotic activity in iliac-femoral and thoracic aortic lesions. Arterioscler. Thromb. 11:1991;1830.
166. Conteras J.A., Lasuncion M.A. Essential differences in cholesteryl ester metabolism between human monocyte-derived and J774 macrophages: evidence against the presence of hormone-sensitive lipase in human macrophages. Arteriosler. Thromb. 14:1994;443.
167. Li F., Hui D.F. Modified low density lipoprotein enhances the secretion of bile salt-stimulated cholesterol esterase by human monocyte-macrophages. J. Biol. Chem. 272:1997;28666.
168. Reue K., Cohen R.D., Schotz M.C. Evidence for hormone-sensitive lipase mRNA expression in human monocyte/macrophages. Arterioscler. Thromb. Vasc. Biol. 17:1997;3428.
169. Stralfors P., Belfrage P. Phosphorylation of hormone-sensitive lipase by cyclic AMP-dependent protein kinase. J. Biol. Chem. 258:1983;15146.
170. Yancey P., St Clair R. Cholesterol efflux is defective in macrophages from atherosclerosis-susceptible White Carneau pigeons relative to resistant Show Racer pigeons. Arterioscler. Thromb. 12:1992;1291.
171. Graham A., Angel A.D.R., Jepson C.A., Yeaman S.J., Hassall D.G. Impaired mobilisation of cholesterol from stored cholesteryl esters in human (THP-1) macrophages. Atherosclerosis. 120:1996;135.
172. Taylor F.R., Kandutsch A.A. Oxysterol binding protein. Chem. Phys. Lipids. 38:1985;187.
173. Ridgway N., Dawson P., Ho Y., Brown M.S., Goldstein J.L. Translocation of oxysterol-binding protein to Golgi apparatus triggered by ligand. J. Cell. Biol. 116:1992;307.
174. Gelissen I.C., Rye K.-A., Brown A.J., Dean R.T., Jessup W. Phospholipid association with apo A-I stimulates oxysterol efflux from macrophage foam cells. Atherosclerosis. 134:1997;367.
175. Gesquiere L., Loreau N., Blache D. Impaired cellular cholesterol efflux by oxysterol-enriched high density lipoproteins. Free. Radic. Biol. Med. 23:1997;541.
176. Parton R.G. Caveolae and caveolins. Curr. Opin. Cell. Biol. 8:1996;542.
177. Baorto D.M., Gao Z., Malaviya R., Dustin M.L., van der Merwe A., Lublin D.M., Abraham S.N. Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic. Nature. 389:1997;636.
178. Kiss A.L., Geuze H.J. Caveolae can be alternative endocytotic structures in elicited macrophages. Eur. J. Cell. Biol. 73:1997;19.
179. Fielding P.E., Fielding C.J. Plasma membrane caveolae mediate the efflux of cellular free cholesterol. Biochemistry. 34:1995;14288.
180. Fielding C.J., Bist A., Fielding P.E. Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers. Proc. Natl. Acad. Sci. USA. 94:1997;3753.
181. Diczfalusy U., Lund E., Lutjohann D., Björkhem I. Novel pathways for elimination of cholesterol by extrahepatic formation of side-chain oxidized oxysterols. Scand. J. Clin. Lab. Invest. Suppl. 226:1996;9.
182. Cader A.A., Steinberg F.M., Mazzone T., Chait A. Mechanisms of enhanced macrophage apoE secretion by oxidized LDL. J. Lipid. Res. 38:1997;981.
183. Paik Y., Chang D., Reardon C., Walker M., Taxman E., Taylor J. Identification and characterisation of transcriptional regulatory regions associated with expression of the human apolipoprotein E gene. J. Biol. Chem. 263:1988;13340.
184. Mattsson-Hulten L., Bondjers G., Wiklund O. Expression of lipoprotein lipase mRNA and secretion in macrophages isolated from human atherosclerotic aorta. J. Clin. Invest. 92:1993;1759.
185. Liu Y., Mattsson-Hulten L., Wiklund O. Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production. Arterioscler. Thromb. Vasc. Biol. 17:1997;317.
186. Jovinge S., Ares M.P.S., Kallin B., Nilsson J. Human monocytes/macrophages release TNF-α in response to Ox-LDL. Arterioscler. Thromb. Vasc. Biol. 16:1996;1573.
187. Ku G., Thomas C.E., Akeson A.L., Jackson R.L. Induction of interleukin 1β expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadecadienoic acid. J. Biol. Chem. 267:1992;14183.
188. Malden T.L., Chait A., Raines E.W., Ross R. The influence of oxidatively modified low density lipoproteins on expression of platelet-derived growth factor by human monocyte-derived macrophages. J. Biol. Chem. 266:1991;13901.
189. Jessup W. Oxidized lipoproteins and nitric oxide. Curr. Opin. Lipidol. 7:1996;274.
190. Plane F., Bruckdorfer K.R., Kerr P., Steuer A., Jacobs M. Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta. Br. J. Pharmacol. 105:1992;216.
191. Liu X.-L., Chen Y., Zhou M., Wan J. Oxidized cholesterol in oxidized low density lipoprotein may be responsible for the inhibition of LPS-induced nitric oxide production in macrophages. Atherosclerosis. 136:1998;43.
192. 2+-calmodulin and caveolin. J. Biol. Chem. 272:1997;15583.
193. Ramasamy S., Boissonneault G.A., Hennig B. Oxysterol-induced endothelial cell dysfunction in culture. J. Am. Coll. Nutr. 11:1992;532.
194. Clare K., Hardwick S.J., Carpenter K.L., Weeratunge N., Mitchinson M.J. Toxicity of oxysterols to human monocyte-macrophages. Atherosclerosis. 118:1995;67.
195. Aupeix K., Weltin D., Mejia J.E., Christ M., Marchal J., Freyssinet J.M., Bischoff P. Oxysterol-induced apoptosis in human monocytic cell lines. Immunobiology. 194:1995;415.
196. Hughes H., Mathews B., Lenz M.L., Guyton J.R. Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol. Arterioscler. Thromb. 14:1994;1177.
197. Peng S., Tham P., Taylor C., Mikkelson B. Cytotoxicity of oxidation derivatives of cholesterol on cultured aortic smooth muscle cells and their effect on cholesterol biosynthesis. Am. J. Clin. Nutr. 32:1979;1033.
198. Christ M., Luu B., Mejia J.E., Moosbrugger I., Bischoff P. Apoptosis induced by oxysterols in murine lymphoma cells and in normal thymocytes. Immunology. 78:1993;455.
199. Ball R., Stowers E., Burton J., Cary N., Skepper J., Michinson M. Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. Athersclerosis. 114:1995;45.
200. Nishio E., Watanabe Y. Oxysterols induced apoptosis in cultured smooth muscle cells through CPP32 protease activation and bcl-2 protein downregulation. Biochem. Biophys. Res. Commun. 226:1996;928.
201. Colles S., Irwin K., Chisolm G. Role of multiple oxidized LDL lipids in cellular injury: dominance of 7β-hydroperoxycholesterol. J. Lipid. Res. 37:1996;2018.
202. Zhang J., Xue Y., Jondal M., Sjovall J. 7α-Hydroxylation and 3-dehydrogenation abolish the ability of 25-hydroxycholesterol and 27-hydroxycholesterol to induce apoptosis in thymocytes. Eur. J. Biochem. 247:1997;129.
203. Ayala T.S., Moller P.C., Johnson B.H., Thompson E.B. Characteristics of 25-hydroxycholesterol-induced apoptosis in the human leukemic cell line CEM. Exp. Cell. Res. 235:1997;35.
204. Harada K., Ishibashi S., Miyashita T. et al. Bcl-2 protein inhibits oxysterol-induced apoptosis through suppressing CPP32-mediated pathway. FEBS. Lett. 411:1997;63.
205. Hyun J.W., Weltin D., Holl V., Marchal J., Dufour P., Luu B., Bischoff P. Cytotoxic properties of a phosphoglycoconjugated derivative of 7β-hydroxycholesterol upon normal and tumor cells in culture. Anticancer. Res. 17:1997;2621.
206. Johnson B.H., Ayala T.S., Chan L.N., El N.M., Thompson E.B. Glucocorticoid/oxysterol-induced DNA lysis in human leukemic cells. J. Steroid. Biochem. Mol. Biol. 61:1997;35.
207. Hegyi L., Skepper J.N., Cary N.R., Mitchinson M.J. Foam cell apoptosis and the development of the lipid core of human atherosclerosis. J. Pathol. 180:1996;423.
208. Jovinge S., Crisby M., Thyberg J., Nilsson J. DNA fragmentation and ultrastructural changes of degenerating cells in atherosclerotic lesions and smooth muscle cells exposed to oxidized LDL in vitro. Arterioscler. Thromb. Vasc. Biol. 17:1997;2225.
209. Cai W., Devaux B., Schaper W., Schaper J. The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions. Atherosclerosis. 131:1997;177.
210. Crisby M., Kallin B., Thyberg J., Zhivotovsky B., Orrenius S., Kostulas V., Nilsson J. Cell death in human atherosclerotic plaques involves both oncosis and apoptosis. Atherosclerosis. 130:1997;17.
211. Mallat Z., Ohan J., Leseche G., Tedgui A. Colocalization of CPP-32 with apoptotic cells in human atherosclerotic plaques. Circulation. 96:1997;424.
212. Escargueil B.I., Meilhac O., Pieraggi M.T., Arnal J.F., Salvayre R., Negre S.A. Oxidized LDLs induce massive apoptosis of cultured human endothelial cells through a calcium-dependent pathway. Prevention by aurintricarboxylic acid. Arterioscler. Thromb. Vasc. Biol. 17:1997;331.
213. Dimmeler S., Haendeler J., Galle J., Zeiher A.M. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the response to injury hypothesis. Circulation. 95:1997;1760.
214. Hessler J., Morel D., Lewis L., Chisholm G. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis. 3:1983;215.
215. Krut LH, Yang JW, Schonfeld G, Ostlund J, R.E. The effect of oxidizing cholesterol in gastrointestinal absorption, plasma clearance, tissue distribution, and processing by endothelial cells. Arterioscler Thromb Vasc Biol 1997;17:778.
216. Wiseman S.A., van den Boom M.A.P., de Fouw N.J., Groot Wassink M., op den Kamp J.A.F., Tijburg L.B.M. Comparison of the effects of dietary vitamin E on in vivo and in vitro parameters of lipid peroxidation in the rabbit. Free. Radic. Biol. Med. 19:1995;617.
217. Appleqvist L.-A., Dutta P.C. Reduction of polyunsaturated fatty acid- and cholesterol-oxidation in diabetics supplemented with antioxidants (abstract). Oxygen. '95. 53:1995;1.
218. Mahfouz M.M., Kawano H., Kummerow F.A. Effect of cholesterol-rich diets with and without added vitamins E and C on the severity of atherosclerosis in rabbits. Am. J. Clin. Nutr. 66:1997;1240.
219. Freyschuss A., Xiu R.J., Zhang J. et al. Vitamin C reduces cholesterol-induced microcirculatory changes in rabbits. Arterioscler. Thromb. Vasc. Biol. 17:1997;1178.
220. Koopman B.J., van der Molen J.C., Wolthers B.G. Determination of some hydroxycholesterols in human serum samples. J. Chromatogr. 416:1987;1.
221. Kucuk O., Churley M., Goodman M.T., Franke A., Custer L., Wilkens L.R., St Pyrek J. Increased plasma level of cholesterol-5β,6β-epoxides in endometrial cancer patients. Cancer. Epidemiol. Biomarkers. Prev. 3:1994;571.
222. Sevanian A., Seraglia R., Traldi P., Rossato P., Ursini F., Hodis H. Analysis of plasma cholesterol oxidation products using gas- and high-performance liquid chromatography/mass spectrometry. Free. Radic. Biol. Med. 17:1994;397.
223. Cook R.P., MacDougall J.D.B. Experimental atherosclerosis in rabbits after feeding cholestanetriol. Br. J. Exp. Pathol. 49:1968;265.
224. Shih J.C.H. Increased atherogenicity of oxidized cholesterol. Fed. Proc. (Abstract). 39:1980;650.
225. Matthias D., Becker C.-H., Godicke W., Schmidt R., Ponsold K. Action of cholestane-3β,5α,6β-triol on rats with particular reference to the aorta. Atherosclerosis. 63:1987;115.
226. Sunde M.L., Lalich J.J. Renal and blood vessel response to oxidized cholesterol in chicks and quails. Fed. Proc. (Abstract). 44:1985;939.
227. Aramaki Y., Kobayashi T., Imai Y., Kikuchi S., Matsukawa T., Kanazawa K. Biological studies of cholestane-3β,5α,6β-triol and its derivatives. Part 1. Hypocholesterolemic effects in rabbits, chickens and rats on atherogenic diet. J. Atheroscler. Res. 7:1967;653.
228. Griminger P., Fisher H. The effect of dried and fresh eggs on plasma cholesterol and atherosclerosis in chickens. Poultry. Sci. 65:1986;979.
229. Higley N.A., Beery J.T., Taylor S.L., Porter S.L., Dzuiba J.A., Lalich J.J. Comparative atherogenic effects of cholesterol and cholesterol oxides. Atherosclerosis. 62:1986;91.
230. Santillan G., Sarma J.S.M., Pawlik G., Rackl A., Grenier A., Bing R.J. Toxicity, pharmacokinetics, and cholesterol-inhibitory effect of 7-ketocholesterol. Atherosclerosis. 35:1980;1.
231. Toda T., Leszczynski D., Kummerow F. Angiotoxic effects of dietary 7-ketocholesterol in chick aorta. Paroi. Arterielle. 12:1981;167.
232. Bernheimer A.W., Robinson W.G., Linder R. et al. Toxicity of enzymically-oxidized low-density lipoprotein. Biochem. Biophys. Res. Comm. 148:1987;260.